Steven Collis, CEO of Chesterbrook-based AmerisourceBergen, does not feel threatened by Amazon’s push into the drug industry, despite its recent purchase of the online pharmacy company PillPack, writes Susie Gharib for Fortune magazine.

“I suspect it’s going to be a very, very long term before this could be a really significant force,” Collis said.

AmerisourceBergen is a powerful player in pharmaceutical industry and the 12th-largest company on the Fortune 500. It sells generic and brand-name drugs to a wide number of healthcare providers.

[uam_ad id=”79356″]

PillPack is a startup with a small stake in the drug industry, but already has pharmacy licenses in all 50 states. Now that it has been acquired by Amazon, many experts believe it could be the catalyst for changing how people shop for drugs and their prices.

Drug prices are currently on President Donald Trump’s radar, and Collis agrees that a new era of lower pricing is approaching.

“I think there’s tremendous sensitivity to too-high price increases,” he said. “I think manufacturers are having to think of their pricing strategies very differently.”

Read more about Steven Collis and AmerisourceBergen in Fortune magazine here.

[uam_ad id=”79583″]